A Novel Combination of Prion Strain Co-Occurrence in Patients with Sporadic Creutzfeldt-Jakob Disease

Atsushi Kobayashi, Yasushi Iwasaki, Masaki Takao, Yuko Saito, Toru Iwaki, Zechen Qi, Ryouta Torimoto, Taishi Shimazaki, Yoshiko Munesue, Norikazu Isoda, Hirofumi Sawa, Keisuke Aoshima, Takashi Kimura, Hinako Kondo, Shirou Mohri, Tetsuyuki Kitamoto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Six subgroups of sporadic Creutzfeldt-Jakob disease have been identified by distinctive clinicopathologic features, genotype at polymorphic codon 129 [methionine (M)/valine (V)] of the PRNP gene, and type of abnormal prion proteins (type 1 or 2). In addition to the pure subgroups, mixed neuropathologic features and the coexistence of two types of abnormal prion proteins in the same patient also have been reported. Here, we found that a portion of the patients previously diagnosed as MM1 had neuropathologic characteristics of the MM2 thalamic form (ie, neuronal loss of the inferior olivary nucleus of the medulla). Furthermore, coexistence of biochemical features of the MM2 thalamic form also was confirmed in the identified cases. In addition, in transmission experiments using prion protein–humanized mice, the brain material from the identified case showed weak infectivity and generated characteristic abnormal prion proteins in the inoculated mice resembling those after inoculation with brain material of MM2 thalamic form. Taken together, these results show that the co-occurrence of MM1 and MM2 thalamic form is a novel entity of sporadic Creutzfeldt-Jakob disease prion strain co-occurrence. The present study raises the possibility that the co-occurrence of the MM2 thalamic form might have been overlooked so far because of the scarcity of abnormal prion protein accumulation and restricted neuropathology.

Original languageEnglish
Pages (from-to)1276-1283
Number of pages8
JournalAmerican Journal of Pathology
Volume189
Issue number6
DOIs
Publication statusPublished - Jun 1 2019

Fingerprint

Prions
Olivary Nucleus
Brain
Valine
Codon
Methionine
Genotype
Sporadic Creutzfeldt-Jakob Disease
Prion Proteins
Genes

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

A Novel Combination of Prion Strain Co-Occurrence in Patients with Sporadic Creutzfeldt-Jakob Disease. / Kobayashi, Atsushi; Iwasaki, Yasushi; Takao, Masaki; Saito, Yuko; Iwaki, Toru; Qi, Zechen; Torimoto, Ryouta; Shimazaki, Taishi; Munesue, Yoshiko; Isoda, Norikazu; Sawa, Hirofumi; Aoshima, Keisuke; Kimura, Takashi; Kondo, Hinako; Mohri, Shirou; Kitamoto, Tetsuyuki.

In: American Journal of Pathology, Vol. 189, No. 6, 01.06.2019, p. 1276-1283.

Research output: Contribution to journalArticle

Kobayashi, A, Iwasaki, Y, Takao, M, Saito, Y, Iwaki, T, Qi, Z, Torimoto, R, Shimazaki, T, Munesue, Y, Isoda, N, Sawa, H, Aoshima, K, Kimura, T, Kondo, H, Mohri, S & Kitamoto, T 2019, 'A Novel Combination of Prion Strain Co-Occurrence in Patients with Sporadic Creutzfeldt-Jakob Disease', American Journal of Pathology, vol. 189, no. 6, pp. 1276-1283. https://doi.org/10.1016/j.ajpath.2019.02.012
Kobayashi, Atsushi ; Iwasaki, Yasushi ; Takao, Masaki ; Saito, Yuko ; Iwaki, Toru ; Qi, Zechen ; Torimoto, Ryouta ; Shimazaki, Taishi ; Munesue, Yoshiko ; Isoda, Norikazu ; Sawa, Hirofumi ; Aoshima, Keisuke ; Kimura, Takashi ; Kondo, Hinako ; Mohri, Shirou ; Kitamoto, Tetsuyuki. / A Novel Combination of Prion Strain Co-Occurrence in Patients with Sporadic Creutzfeldt-Jakob Disease. In: American Journal of Pathology. 2019 ; Vol. 189, No. 6. pp. 1276-1283.
@article{d693f38609db4340a554d840a19dc50c,
title = "A Novel Combination of Prion Strain Co-Occurrence in Patients with Sporadic Creutzfeldt-Jakob Disease",
abstract = "Six subgroups of sporadic Creutzfeldt-Jakob disease have been identified by distinctive clinicopathologic features, genotype at polymorphic codon 129 [methionine (M)/valine (V)] of the PRNP gene, and type of abnormal prion proteins (type 1 or 2). In addition to the pure subgroups, mixed neuropathologic features and the coexistence of two types of abnormal prion proteins in the same patient also have been reported. Here, we found that a portion of the patients previously diagnosed as MM1 had neuropathologic characteristics of the MM2 thalamic form (ie, neuronal loss of the inferior olivary nucleus of the medulla). Furthermore, coexistence of biochemical features of the MM2 thalamic form also was confirmed in the identified cases. In addition, in transmission experiments using prion protein–humanized mice, the brain material from the identified case showed weak infectivity and generated characteristic abnormal prion proteins in the inoculated mice resembling those after inoculation with brain material of MM2 thalamic form. Taken together, these results show that the co-occurrence of MM1 and MM2 thalamic form is a novel entity of sporadic Creutzfeldt-Jakob disease prion strain co-occurrence. The present study raises the possibility that the co-occurrence of the MM2 thalamic form might have been overlooked so far because of the scarcity of abnormal prion protein accumulation and restricted neuropathology.",
author = "Atsushi Kobayashi and Yasushi Iwasaki and Masaki Takao and Yuko Saito and Toru Iwaki and Zechen Qi and Ryouta Torimoto and Taishi Shimazaki and Yoshiko Munesue and Norikazu Isoda and Hirofumi Sawa and Keisuke Aoshima and Takashi Kimura and Hinako Kondo and Shirou Mohri and Tetsuyuki Kitamoto",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.ajpath.2019.02.012",
language = "English",
volume = "189",
pages = "1276--1283",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - A Novel Combination of Prion Strain Co-Occurrence in Patients with Sporadic Creutzfeldt-Jakob Disease

AU - Kobayashi, Atsushi

AU - Iwasaki, Yasushi

AU - Takao, Masaki

AU - Saito, Yuko

AU - Iwaki, Toru

AU - Qi, Zechen

AU - Torimoto, Ryouta

AU - Shimazaki, Taishi

AU - Munesue, Yoshiko

AU - Isoda, Norikazu

AU - Sawa, Hirofumi

AU - Aoshima, Keisuke

AU - Kimura, Takashi

AU - Kondo, Hinako

AU - Mohri, Shirou

AU - Kitamoto, Tetsuyuki

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Six subgroups of sporadic Creutzfeldt-Jakob disease have been identified by distinctive clinicopathologic features, genotype at polymorphic codon 129 [methionine (M)/valine (V)] of the PRNP gene, and type of abnormal prion proteins (type 1 or 2). In addition to the pure subgroups, mixed neuropathologic features and the coexistence of two types of abnormal prion proteins in the same patient also have been reported. Here, we found that a portion of the patients previously diagnosed as MM1 had neuropathologic characteristics of the MM2 thalamic form (ie, neuronal loss of the inferior olivary nucleus of the medulla). Furthermore, coexistence of biochemical features of the MM2 thalamic form also was confirmed in the identified cases. In addition, in transmission experiments using prion protein–humanized mice, the brain material from the identified case showed weak infectivity and generated characteristic abnormal prion proteins in the inoculated mice resembling those after inoculation with brain material of MM2 thalamic form. Taken together, these results show that the co-occurrence of MM1 and MM2 thalamic form is a novel entity of sporadic Creutzfeldt-Jakob disease prion strain co-occurrence. The present study raises the possibility that the co-occurrence of the MM2 thalamic form might have been overlooked so far because of the scarcity of abnormal prion protein accumulation and restricted neuropathology.

AB - Six subgroups of sporadic Creutzfeldt-Jakob disease have been identified by distinctive clinicopathologic features, genotype at polymorphic codon 129 [methionine (M)/valine (V)] of the PRNP gene, and type of abnormal prion proteins (type 1 or 2). In addition to the pure subgroups, mixed neuropathologic features and the coexistence of two types of abnormal prion proteins in the same patient also have been reported. Here, we found that a portion of the patients previously diagnosed as MM1 had neuropathologic characteristics of the MM2 thalamic form (ie, neuronal loss of the inferior olivary nucleus of the medulla). Furthermore, coexistence of biochemical features of the MM2 thalamic form also was confirmed in the identified cases. In addition, in transmission experiments using prion protein–humanized mice, the brain material from the identified case showed weak infectivity and generated characteristic abnormal prion proteins in the inoculated mice resembling those after inoculation with brain material of MM2 thalamic form. Taken together, these results show that the co-occurrence of MM1 and MM2 thalamic form is a novel entity of sporadic Creutzfeldt-Jakob disease prion strain co-occurrence. The present study raises the possibility that the co-occurrence of the MM2 thalamic form might have been overlooked so far because of the scarcity of abnormal prion protein accumulation and restricted neuropathology.

UR - http://www.scopus.com/inward/record.url?scp=85065614688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065614688&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2019.02.012

DO - 10.1016/j.ajpath.2019.02.012

M3 - Article

C2 - 30926338

AN - SCOPUS:85065614688

VL - 189

SP - 1276

EP - 1283

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 6

ER -